Purpose: To assess a whole-body vibration (WBV) intervention for children after cancer treatment.
Methods: Eleven children after inpatient anticancer therapy participated in a 12-week supervised WBV intervention, which consisted of one 9- to 13-minute WBV session per week, with 5 to 9 minutes' overall vibration time. Feasibility was defined as the ability to participate in WBV training without reporting adverse events. The number of offered and completed training sessions, program acceptance, and measures of function were assessed.
Results: Nine participants completed the WBV intervention without any WBV-related adverse events. The adherence rate was 87.96%. Only minor side effects were reported and there was general program acceptance. We found indications that WBV has positive effects on knee extensor strength and active ankle dorsiflexion range of motion.
Conclusions: WBV was feasible, safe, and well received among children after inpatient anticancer therapy. No health deteriorations were observed. Positive effects need to be confirmed in future trials.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/PEP.0000000000000536 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Over 40% of cancer patients use complementary and alternative medications while receiving anticancer treatment.
Eur J Hosp Pharm
December 2024
Clinical Pharmacology and Pharmacy, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands
Background: The use of complementary and alternative medications (CAM) is popular among cancer patients. CAM includes vitamins, minerals, phytotherapy, homeopathy, nutritional supplements and probiotics. CAM use may lead to unwanted risks by interacting with anticancer drugs; therefore, it is important for healthcare providers to be aware of CAM use by their patients.
View Article and Find Full Text PDFInteractions of warfarin with COVID-19 vaccine/drugs, monoclonal antibodies, and targeted anticancer agents from real-world data mining.
Front Pharmacol
November 2024
Department of Infectious Diseases and Public Health, City University of Hong Kong, Hong Kong SAR, China.
Objective: This study aims to examine the unresolved drug-drug interactions of warfarin using real-world data.
Methods: Electronic medical records from a hospital in Shanghai, China, were used to summarize drug-related problems (DRPs) among inpatients taking warfarin in 2022. Additionally, adverse event data for warfarin from January 2004 to December 2023 were extracted from the U.
Grip-Strength-Lean-Mass Index (GSLMI) as a valuable tool for sarcopenia diagnosis and survival prognosis in cancer patients: a nationwide multicenter cohort study.
J Nutr Health Aging
January 2025
Department of Clinical Nutrition, Daping Hospital, Army Medical University (Third Military Medical University), Chongqing, 400042, China; Chongqing Municipal Health Commission Key Laboratory of Intelligent Clinical Nutrition and Transformation, Chongqing, 400042, China. Electronic address:
Objectives: To identify whether the Grip-Strength-Lean-Mass Index (GSLMI) can precisely diagnose sarcopenia and predict prognosis for cancer patients in clinical settings.
Design: A nationwide multicenter cohort study.
Setting And Participants: 8,831 inpatients aged 18 years and older, histologically diagnosed with cancer and receiving anti-cancer therapy.
External validation of the Khorana score for the prediction of venous thromboembolism in cancer patients: A systematic review and meta-analysis.
Int J Nurs Stud
November 2024
Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, China. Electronic address:
Background: Venous thromboembolism is the leading cause of death in cancer patients, second only to tumor progression. The Khorana score is recommended by clinical guidelines for identifying ambulatory cancer patients at high risk of venous thromboembolism during chemotherapy. However, its predictive performance is debated among cancer patients.
View Article and Find Full Text PDFEffective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment.
Palliat Care Soc Pract
June 2024
Department of Hematology, Oncology, and Tumor Immunology, Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Article Synopsis
- The study looks at how early palliative care can help improve the quality of life for patients with metastatic renal cell carcinoma (mRCC) who experience severe symptoms, a crucial aspect not previously examined in depth.
- Patients with mRCC were admitted to a palliative care unit, and their symptoms were tracked before, during, and after treatment, revealing that many suffered from pain, dyspnea, fatigue, and the need for assistance.
- Results showed that multidisciplinary palliative care significantly reduced symptom scores and pain levels, indicating the effectiveness of integrating palliative care early in treatment for mRCC patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!